These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23836805)

  • 1. Heart grafts tolerized through third-party multipotent adult progenitor cells can be retransplanted to secondary hosts with no immunosuppression.
    Eggenhofer E; Popp FC; Mendicino M; Silber P; Van't Hof W; Renner P; Hoogduijn MJ; Pinxteren J; van Rooijen N; Geissler EK; Deans R; Schlitt HJ; Dahlke MH
    Stem Cells Transl Med; 2013 Aug; 2(8):595-606. PubMed ID: 23836805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I).
    Popp FC; Fillenberg B; Eggenhofer E; Renner P; Dillmann J; Benseler V; Schnitzbauer AA; Hutchinson J; Deans R; Ladenheim D; Graveen CA; Zeman F; Koller M; Hoogduijn MJ; Geissler EK; Schlitt HJ; Dahlke MH
    J Transl Med; 2011 Jul; 9():124. PubMed ID: 21798013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation.
    Soeder Y; Loss M; Johnson CL; Hutchinson JA; Haarer J; Ahrens N; Offner R; Deans RJ; Van Bokkelen G; Geissler EK; Schlitt HJ; Dahlke MH
    Stem Cells Transl Med; 2015 Aug; 4(8):899-904. PubMed ID: 26041737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
    Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
    Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-Grade Human Multipotent Adult Progenitor Cells Block CD8+ Cytotoxic T Lymphocytes.
    Plessers J; Dekimpe E; Van Woensel M; Roobrouck VD; Bullens DM; Pinxteren J; Verfaillie CM; Van Gool SW
    Stem Cells Transl Med; 2016 Dec; 5(12):1607-1619. PubMed ID: 27465071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.
    Casiraghi F; Azzollini N; Cassis P; Imberti B; Morigi M; Cugini D; Cavinato RA; Todeschini M; Solini S; Sonzogni A; Perico N; Remuzzi G; Noris M
    J Immunol; 2008 Sep; 181(6):3933-46. PubMed ID: 18768848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of neonatal immunoregulatory cells and cyclosporine on the heart allograft survival in rats.
    Skowron-Cendrzak A; Garlicki M; Kubera M
    Pol J Pharmacol; 1994; 46(3):181-3. PubMed ID: 8000452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mechanisms underlying differential rejection of sequential heart and lung allografts in rats.
    Moller F; Hoyt G; Farfan F; Starnes VA; Clayberger C
    Transplantation; 1993 Mar; 55(3):650-5. PubMed ID: 8456486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differences.
    Miyagawa S; Stepkowski SM; Lawen JG; Rutzky LP; Kahan BD
    Transplantation; 1991 Nov; 52(5):851-7. PubMed ID: 1835196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells.
    Fujiki M; Esquivel CO; Martinez OM; Strober S; Uemoto S; Krams SM
    Liver Transpl; 2010 Feb; 16(2):147-54. PubMed ID: 20104482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells.
    Andoins C; de Fornel D; Annat J; Dutartre P
    Transplantation; 1996 Dec; 62(11):1543-9. PubMed ID: 8970605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of allogeneic mixed chimerism by immature dendritic cells and bone marrow transplantation leads to prolonged tolerance to major histocompatibility complex disparate allografts.
    Yu P; Xiong S; He Q; Chu Y; Lu C; Ramlogan CA; Steel JC
    Immunology; 2009 Aug; 127(4):500-11. PubMed ID: 19604303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immunosuppression by postoperative infusion of allogeneic spleen cells: requirement of donor major histocompatibility complex expression and graft-versus-host reactivity.
    Tsui TY; Deiwick A; Ko S; Schlitt HJ
    Transplantation; 2000 Jan; 69(1):25-30. PubMed ID: 10653375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durability of donor-specific and organ-specific heart transplant tolerance induced by intrathymic pretreatment with allogeneic spleen cells.
    Shen Z; Mohiuddin M; Goldstein C; Yokoyama H; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Feb; 111(2):429-31. PubMed ID: 8583817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.